{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:52:07Z","timestamp":1781632327588,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MDA Hellas","award":["Grant Number 01\/23.02.2022"],"award-info":[{"award-number":["Grant Number 01\/23.02.2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal Muscular Atrophy (SMA) carries a heavy burden for patients and caregivers, which, in Greece, is exacerbated by resource constraints and limited care integration. To-date, there were only anecdotal descriptions of - mostly pediatric - SMA patient journey challenges. This survey amongst a population of adult patients with SMA (May \u2013 September 2023) reports on their journey\u2019s challenges and supports advocacy to improve their experience and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A novel questionnaire was developed, which recorded basic sociodemographic characteristics, disease history, disease-related financial burden, and mapped the full patient journey per disease phase. In addition, participants self-assessed their functional autonomy and quality of life (QoL). All adults diagnosed and living with SMA were eligible to participate. Participants received an invitation by MDA to complete the questionnaire online. Multiple linear regression analysis was used to find factors associated with QoL and functional autonomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-seven adult SMA patients with a mean age of 35.9 years participated in the survey. Results confirm their complicated journey and the related financial and QoL burden the condition results in. Participants spent an average of over EUR 300 a month for their condition, primarily on physiotherapy sessions, therapy aids and food supplements, and this impacted on their QoL. Higher education was positively correlated with QoL, underlying the importance of early SMA patient integration in school life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This survey reports patient journeys of adult SMA patients and as such adds to the more extensive literature on parents\u2019 or caregivers\u2019 experience with pediatric SMA. There is a need to showcase adult SMA patients\u2019 experience with care and the impact the condition has on their financial outlook and QoL. All data are self-reported. Some refer to events over a decade ago and may, thus, be affected by recall bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>As SMA management evolves with the wider availability of novel treatments and patients live well into adulthood, so must healthcare systems reconsider patient pathways to ensure patients optimize use of available resources in the most efficient manner.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04165-6","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:28:49Z","timestamp":1768994929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the patient journey of adult patients with Spinal Muscular Atrophy in Greece: key challenges and priorities for action"],"prefix":"10.1186","volume":"21","author":[{"given":"Christina","family":"Golna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chara","family":"Tzavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Vasileiadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Golnas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornilia","family":"Binou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigone","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-9444","authenticated-orcid":false,"given":"Kyriakos","family":"Souliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"5","key":"4165_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.nmd.2021.01.012","volume":"31","author":"N Gusset","year":"2021","unstructured":"Gusset N, Stalens C, Stumpe E, Klouvi L, Mejat A, Ouillade M-C, et al. Understanding European patient expectations towards current therapeutic development in spinal muscular atrophy. Neuromuscul Disord. 2021;31(5):419\u201330.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"4165_CR2","doi-asserted-by":"publisher","first-page":"e0230677","DOI":"10.1371\/journal.pone.0230677","volume":"15","author":"MC Pera","year":"2020","unstructured":"Pera MC, Coratti G, Berti B, D\u2019Amico A, Sframeli M, Albamonte E, et al. Diagnostic journey in spinal muscular atrophy: is it still an odyssey? PLoS ONE. 2020;15(3):e0230677.","journal-title":"PLoS ONE"},{"key":"4165_CR3","unstructured":"TREAT-NMD. 2017 Standards of Care for Spinal Muscular Atrophy (SMA). https:\/\/www.treat-nmd.org\/resources-and-support\/care-guides\/sma-care\/; 2017."},{"issue":"3","key":"4165_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197\u2013207.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"4165_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"4165_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13023-022-02407-5","volume":"17","author":"M Brandt","year":"2022","unstructured":"Brandt M, Johannsen L, Inhestern L, Bergelt C. Parents as informal caregivers of children and adolescents with spinal muscular atrophy: a systematic review of quantitative and qualitative data on the psychosocial situation, caregiver burden, and family needs. Orphanet J Rare Dis. 2022;17(1):274.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"4165_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5152\/TurkArchPediatr.2021.20117","volume":"56","author":"AE Acar","year":"2021","unstructured":"Acar AE, Sayg\u0131 EK, \u0130mamo\u011flu S, \u00d6zt\u00fcrk G, \u00dcnver O, Ergenekon P, et al. The burden of primary caregivers of spinal muscular atrophy patients and their needs. Turkish Archives Pediatr. 2021;56(4):366.","journal-title":"Turkish Archives Pediatr"},{"issue":"4","key":"4165_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40271-020-00415-w","volume":"13","author":"MA Farrar","year":"2020","unstructured":"Farrar MA, Carey KA, Paguinto S-G, Kasparian NA, De Abreu Louren\u00e7o R. The whole game is changing and you\u2019ve got hope: Australian perspectives on treatment decision making in spinal muscular atrophy. Patient - Patient-Centered Outcomes Res. 2020;13(4):389\u2013400.","journal-title":"Patient - Patient-Centered Outcomes Res"},{"key":"4165_CR9","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.eclinm.2021.100742","volume":"33","author":"DST Kariyawasam","year":"2021","unstructured":"Kariyawasam DST, D\u2019Silva AM, Vetsch J, Wakefield CE, Wiley V, Farrar MA. We needed this: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy. EClinicalMedicine. 2021;33:100742.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"4165_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ejhg.2014.147","volume":"23","author":"S Lawton","year":"2015","unstructured":"Lawton S, Hickerton C, Archibald AD, McClaren BJ, Metcalfe SA. A mixed methods exploration of families\u2019 experiences of the diagnosis of childhood spinal muscular atrophy. Eur J Hum Genet. 2015;23(5):575\u201380.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"4165_CR11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/cch.13014","volume":"48","author":"ILB Oude Lansink","year":"2022","unstructured":"Oude Lansink ILB, van Stam PCC, Schafrat E, Mocking M, Prins SD, Beelen A, et al. This battle, between your gut feeling and your mind. Try to find the right balance\u2019: parental experiences of children with spinal muscular atrophy during COVID-19 pandemic. Child Care Health Dev. 2022;48(6):1062\u201370.","journal-title":"Child Care Health Dev"},{"issue":"7","key":"4165_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/dmcn.14825","volume":"63","author":"M van Kruijsbergen","year":"2021","unstructured":"van Kruijsbergen M, Schr\u00f6der CD, van der Ketelaar M, van der Cuppen I, et al. Parents\u2019 perspectives on Nusinersen treatment for children with spinal muscular atrophy. Dev Med Child Neurol. 2021;63(7):816\u201323.","journal-title":"Dev Med Child Neurol"},{"issue":"7s","key":"4165_CR13","doi-asserted-by":"publisher","first-page":"s745","DOI":"10.1016\/S0929-693X(20)30277-3","volume":"27","author":"J Ropars","year":"2020","unstructured":"Ropars J, Peudenier S, Genot A, Barnerias C, Espil C. Multidisciplinary approach and psychosocial management of spinal muscular atrophy (SMA). Arch Pediatr. 2020;27(7s):s745\u201379.","journal-title":"Arch Pediatr"},{"issue":"2","key":"4165_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10916-005-3006-6","volume":"29","author":"K Souliotis","year":"2005","unstructured":"Souliotis K, Lionis C. Creating an integrated health care system in greece: a primary care perspective. J Med Syst. 2005;29(2):187\u201396.","journal-title":"J Med Syst"},{"issue":"3","key":"4165_CR15","first-page":"455","volume":"20","author":"K Athanasakis","year":"2012","unstructured":"Athanasakis K, Souliotis K, Kyriopoulos E-J, Loukidou E, Kritikou P, Kyriopoulos J. Inequalities in access to cancer treatment: an analysis of cross-regional patient mobility in Greece. Support Care Cancer. 2012;20(3):455\u201360.","journal-title":"Support Care Cancer"},{"key":"4165_CR16","doi-asserted-by":"crossref","unstructured":"Kanavos P, Souliotis K. Reforming health care in greece: balancing fiscal adjustment with health care needs. In: Meghir C, Pissarides CA, Vayanos D, Vettas N, editors. Beyond austerity: reforming the Greek economy. The MIT Press Ltd; 2017. pp. 359\u2013402.","DOI":"10.7551\/mitpress\/9780262035835.003.0009"},{"issue":"6","key":"4165_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.healthpol.2021.04.001","volume":"125","author":"TV Giannouchos","year":"2021","unstructured":"Giannouchos TV, Ukert B, Vozikis A, Steletou E, Souliotis K. Informal out-of-pocket payments experience and individuals\u2019 willingness-to-pay for healthcare services in Greece. Health Policy. 2021;125(6):693\u2013700.","journal-title":"Health Policy"},{"issue":"3","key":"4165_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JND-190466","volume":"7","author":"K Kekou","year":"2020","unstructured":"Kekou K, Svingou M, Sofocleous C, Mourtzi N, Nitsa E, Konstantinidis G, et al. Evaluation of genotypes and epidemiology of spinal muscular atrophy in greece: A nationwide study spanning 24 years. J Neuromuscul Dis. 2020;7(3):247\u201356.","journal-title":"J Neuromuscul Dis"},{"key":"4165_CR19","first-page":"293","volume-title":"The impact and implications of crisis: A comprehensive approach combining elements of health and society","author":"K Souliotis","year":"2018","unstructured":"Souliotis K. Facing the impact of persistent economic crisis on healthcare in greece: the need for a new financing paradigm. In: Saridi M, Souliotis K, editors. The impact and implications of crisis: A comprehensive approach combining elements of health and society. New York: Nova Science; 2018. pp. 293\u2013301."},{"issue":"1","key":"4165_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.23736\/S1973-9087.23.08056-5","volume":"60","author":"S Ferfeli","year":"2024","unstructured":"Ferfeli S, Galanos A, Dontas IA, Triantafyllou A, Triantafyllopoulos IK, Chronopoulos E. Reliability and validity of the Greek adaptation of the modified Barthel index in neurorehabilitation patients. Eur J Phys Rehabil Med. 2024;60(1):44\u201354.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"7","key":"4165_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1524-4733.2008.00356.x","volume":"11","author":"N Kontodimopoulos","year":"2008","unstructured":"Kontodimopoulos N, Pappa E, Niakas D, Yfantopoulos J, Dimitrakaki C, Tountas Y. Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health. 2008;11(7):1162\u20139.","journal-title":"Value Health"},{"issue":"1","key":"4165_CR22","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jval.2021.11.475","volume":"25","author":"F Rumi","year":"2022","unstructured":"Rumi F, Calabr\u00f2 GE, Coratti G, Pera M, Baldini V, Lauro D, et al. POSC70 the economic and social burden of spinal muscular atrophy (SMA) in the Italian context. Value Health. 2022;25(1):S100.","journal-title":"Value Health"},{"key":"4165_CR23","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a-Longobardo LM, Aranda-Reneo I, Oliva-Moreno J, Litzkendorf S, Durand-Zaleski I, Tizzano E, et al. The economic impact and Health-Related quality of life of spinal muscular Atrophy. An analysis across Europe. Int J Environ Res Public Health. 2020;17(16).","DOI":"10.3390\/ijerph17165640"},{"issue":"1","key":"4165_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-017-0695-0","volume":"12","author":"J L\u00f3pez-Bastida","year":"2017","unstructured":"L\u00f3pez-Bastida J, Pe\u00f1a-Longobardo LM, Aranda-Reneo I, Tizzano E, Sefton M, Oliva-Moreno J. Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet J Rare Dis. 2017;12(1):141.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4165_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-016-0424-0","volume":"11","author":"C Klug","year":"2016","unstructured":"Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, et al. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016;11(1):58.","journal-title":"Orphanet J Rare Dis"},{"key":"4165_CR26","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1097\/BPO.0000000000001779","volume":"41","author":"SE Koop","year":"2021","unstructured":"Koop SE, Shrader MW. What happens to our neuromuscular patients in adulthood: pathway to independence and maximal function. J Pediatr Orthop. 2021;41:S87\u20139.","journal-title":"J Pediatr Orthop"},{"key":"4165_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/JND-200611","volume":"8","author":"MC Walter","year":"2021","unstructured":"Walter MC, Chiriboga C, Duong T, Goemans N, Mayhew A, Ouillade L, et al. Improving care and empowering adults living with SMA: A call to action in the new treatment era. J Neuromuscul Dis. 2021;8:543\u201351.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"4165_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13023-019-1052-2","volume":"14","author":"HWY Wan","year":"2019","unstructured":"Wan HWY, Carey KA, D\u2019Silva A, Kasparian NA, Farrar MA. Getting ready for the adult world: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet J Rare Dis. 2019;14(1):74.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4165_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/neurolint16050067","volume":"16","author":"B Cavaloiu","year":"2024","unstructured":"Cavaloiu B, Simina I-E, Chisavu L, Vilciu C, Tr\u0103il\u0103 I-A, Puiu M. Quality of life assessment in Romanian patients with spinal muscular atrophy undergoing Nusinersen treatment. Neurol Int. 2024;16(5):891\u2013904.","journal-title":"Neurol Int"},{"issue":"16","key":"4165_CR30","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1080\/09638288.2018.1555864","volume":"42","author":"MJ Fischer","year":"2020","unstructured":"Fischer MJ, Asselman F-L, Kruitwagen-van Reenen ET, Verhoef M, Wadman RI, Visser-Meily JMA, et al. Psychological well-being in adults with spinal muscular atrophy: the contribution of participation and psychological needs. Disabil Rehabil. 2020;42(16):2262\u201370.","journal-title":"Disabil Rehabil"},{"key":"4165_CR31","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/TCRM.S172291","volume":"15","author":"T Dangouloff","year":"2019","unstructured":"Dangouloff T, Servais L. Clinical evidence supporting early treatment of patients with spinal muscular atrophy: current perspectives. Ther Clin Risk Manag. 2019;15:1153\u201361.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"4165_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-020-1339-3","volume":"15","author":"HWY Wan","year":"2020","unstructured":"Wan HWY, Carey KA, D\u2019Silva A, Vucic S, Kiernan MC, Kasparian NA, et al. Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review. Orphanet J Rare Dis. 2020;15(1):70.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4165_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/brainsci13010110","volume":"13","author":"C Wohnrade","year":"2023","unstructured":"Wohnrade C, Velling A-K, Mix L, Wurster CD, Cordts I, Stolte B, et al. Health-related quality of life in spinal muscular atrophy patients and their caregivers\u2014a prospective, cross-sectional, multi-center analysis. Brain Sci. 2023;13(1):110.","journal-title":"Brain Sci"},{"issue":"1","key":"4165_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","volume":"15","author":"Y Qian","year":"2015","unstructured":"Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh W-S. Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study. BMC Neurol. 2015;15(1):217.","journal-title":"BMC Neurol"},{"issue":"6","key":"4165_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/mus.26201","volume":"58","author":"ET van der Kruitwagen-van Reenen","year":"2018","unstructured":"van der Kruitwagen-van Reenen ET, Schr\u00f6der C, van den Wadman RI, Visser-Meily JMA, et al. Social participation of adult patients with spinal muscular atrophy: Frequency, restrictions, satisfaction, and correlates. Muscle Nerve. 2018;58(6):805\u201311.","journal-title":"Muscle Nerve"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04165-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:55:07Z","timestamp":1781628907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04165-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4165"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04165-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey was approved by the Ethics Committee of the Health Policy Institute and the Board of Directors of MDA and was conducted in line with the ethical standards set by the Declaration of Helsinki. Participation was voluntary, anonymized, and informed consent was requested and obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}